Figure 1.
The role of methionine restriction in impeding tumor growth and its potential to improve outcomes in conjunction with gut microbiome manipulation: Resident gut taxa in the intestinal lumen produce metabolites (top panel) that direct T-cell differentiation and improve responses to immunotherapy (bottom left). Differential tumor growth in methionine enriched and depleted tumor microenvironments (bottom right).